Lipid-lowering effect of flavanomarein on non-alcoholic fatty liver disease based on network pharmacology

Xiaoli WEI; Yanli GUO; Yongwei ZHANG; Zheng RAN; Yi LAN; Lifeng WANG; Xinmin MAO

doi:10.16016/j.1000-5404.202009246

您当前的位置：

首页 >

文章列表页 >

Lipid-lowering effect of flavanomarein on non-alcoholic fatty liver disease based on network pharmacology

更新时间：2026-01-09

- Lipid-lowering effect of flavanomarein on non-alcoholic fatty liver disease based on network pharmacology
- Journal of Third Military Medical University Vol. 43, Issue 5, Pages: 383-394(2021)
- 作者机构：
- 作者简介：
- 基金信息：
  
  the Regional Program of National Natural Science Foundation of China(81460636);the Joint Program of National Natural Science Foundation of China(U1303233)
- DOI：10.16016/j.1000-5404.202009246
  CLC：
- Received：29 September 2020，
  
  Published：15 March 2021
- 稿件说明：
移动端阅览
Xiaoli WEI, Yanli GUO, Yongwei ZHANG, et al. Lipid-lowering effect of flavanomarein on non-alcoholic fatty liver disease based on network pharmacology[J]. Journal of Third Military Medical University, 2021, 43(5): 383-394.
DOI：

Xiaoli WEI, Yanli GUO, Yongwei ZHANG, et al. Lipid-lowering effect of flavanomarein on non-alcoholic fatty liver disease based on network pharmacology[J]. Journal of Third Military Medical University, 2021, 43(5): 383-394. DOI： 10.16016/j.1000-5404.202009246.

摘要

Abstract

Objective

To explore the targets and signaling pathways of flavanomarein in the treatment of non-alcoholic fatty liver disease (NAFLD) by network pharmacology

and to investigate the effect and mechanisms in the treatment.

Methods

① The potential active targets of flavanomarein were retrieved in the Swiss Target Pr

ediction database

and the disease-related targets were searched in the DisGeNET database. The prediction targets of lipid metabolism of NAFLD regulated by flavanomarein was obtained through Venn analysis. The Biso Genet database was used to construct the protein-protein interaction (PPI) network diagram

the Metascape database was used to analyze GO functional enrichment and KEGG pathway enrichment

and the Cytoscape software was used to draw the "target-pathway" network diagram. ② NAFLD db/db mice was employed for

in vivo

verification. Thirty male db/db mice were randomly divided into db/m group

db/db model group

and db/db+flavanomarein group (50 mg/kg). After the administration of 0.5% sodium carboxymethyl cellulose solution and flavanomarein for 12 weeks

the mice were sacrificed

and the liver contents of TG

GSH and GSSG was detected. HE staining and oil red O staining were used to observe the pathological changes of the liver. qRT-PCR and Western blotting were used to detect the mRNA and protein levels of key molecules in the lipid metabolism in the liver. ③HepG2 cells were treated with free fatty acids (FFAs

oleic acid∶palmitic acid =2∶1) and divided into normal group

FFAs treatment group (500 μmol/L)

and FFAs+ low

medium and high concentrations of flavanomarein (25

100 μmol/L) for 24 h. Oil red O staining was used to detect the TG content in HepG2 cells. qRT-PCR and Western blotting were used to detect the mRNA and protein levels of key molecules in the lipid metabolism of HepG2 cells.

Results

① A total of 29 core targets of flavanomarein docking NAFLD were screened through Venn analysis

including peroxisome proliferator-activated receptor-gamma (PPARγ)

vascular endothelial growth factor (VEGF)

and mitogen-activated protein kinase 14 (MAPK14). The GO analysis enriched 6 molecular functions

20 biological processes and 5 cellular components. KEGG analysis enriched 40 key signaling pathways related to the effect of flavanomarein on NAFLD

which

mainly focuses on the AMPK lipid metabolism pathway

insulin resistance (IR) pathway

and apoptosis pathway. ② The results of animal experiments showed that flavanomarein treatment reduced TG level in the NAFLD mice (

0.05) and improved the ratio of GSH/GSSG (

0.05). HE and oil red O staining showed that flavanomarein could reverse hepatocyte enlargement and reduce lipid drop infiltration of hepatocytes. qRT-PCR results showed that the treatment decreased the mRNA levels of ACC1

SCD1

and FASN for lipid synthesis (

0.05)

while increased those of ACOX-1 and CPT1α for β-oxidation (

0.05). Western blot assay results indicated that the expression levels of SREBP and FASN were obviously lower (

0.05)

and those of PPARγ and PPARα were increased (

0.05) in the flavanomarein group than the model group. ③

In vitro

cell experiments showed that flavanomarein reduced the TG content of HepG2 cells (

0.05) and the expression of SREBP

SCD1 and ACC1

but increased the levels of CPT1α and ACOX-1 mRNA (

0.05). And

the protein expression of SREBP and FASN was also significantly reduced (

0.05).

Conclusion

Flavanomarein may play a therapeutic role in NAFLD by improving oxidative stress

up-regulating fatty acid β-oxidation

reducing lipid synthesis through regulating the PPARγ/SREBP/FASN signaling pathway.

关键词

Keywords

references

邵幼林范建高非酒精性脂肪性肝病的流行现状与危害中华肝脏病杂志 2019 27 1 10 13 10.3760/cma.j.issn.1007-3418.2019.01.004 邵幼林, 范建高. 非酒精性脂肪性肝病的流行现状与危害[J]. 中华肝脏病杂志, 2019, 27(1): 10-13. DOI:10.3760/cma.j.issn.1007-3418.2019.01.004.

SHAO Y L FAN J G Prevalence and harm of nonalcoholic fatty liver disease Clin J Hepatol 2019 27 1 10 13 10.3760/cma.j.issn.1007-3418.2019.01.004 SHAO Y L, FAN J G. Prevalence and harm of nonalcoholic fatty liver disease[J]. Clin J Hepatol, 2019, 27(1): 10-13. DOI:10.3760/cma.j.issn.1007-3418.2019.01.004.

HUANG Y LANG H CHEN K Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway Appl Physiol Nutr Metab 2020 45 3 227 239 10.1139/apnm-2019-0057 HUANG Y, LANG H, CHEN K, et al . Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway[J ] . Appl Physiol Nutr Metab, 2020, 45(3): 227-239. DOI:10.1139/apnm-2019-0057.

高燕翔张勇刘裕 SREBP-1c在白藜芦醇预防大鼠非酒精性脂肪肝发生中的作用第三军医大学学报 2015 37 17 1704 1708 10.16016/j.1000-5404.201412125 https://aammt.tmmu.edu.cn/oa/DArticle.aspx?type=view&id=201412125 高燕翔, 张勇, 刘裕, 等. SREBP-1c在白藜芦醇预防大鼠非酒精性脂肪肝发生中的作用[J]. 第三军医大学学报, 2015, 37(17): 1704-1708. DOI: 10.16016/j.1000-5404.201412125.

GAO Y X ZHANG Y LIU Y SREBP-1c is involved in preventive effect of resveratrol on pathogenesis of nonalcoholic fatty liver disease in rats J Third Mil Med Univ 2015 37 17 1704 1708 10.16016/j.1000-5404.201412125 https://aammt.tmmu.edu.cn/oa/DArticle.aspx?type=view&id=201412125 GAO Y X, ZHANG Y, LIU Y, et al . SREBP-1c is involved in preventive effect of resveratrol on pathogenesis of nonalcoholic fatty liver disease in rats[J ] . J Third Mil Med Univ, 2015, 37(17): 1704-1708. DOI: 10.16016/j.1000-5404.201412125.

瞿璐王涛董勇喆菊花化学成分与药理作用的研究进展药物评价研究 2015 38 1 98 104 10.7501/j.issn.1674-6376.2015.01.019 瞿璐, 王涛, 董勇喆, 等. 菊花化学成分与药理作用的研究进展[J]. 药物评价研究, 2015, 38(1): 98-104. DOI:10.7501/j.issn.1674-6376.2015.01.019.

QU L WANG T DONG Y Z Research progress on chemical constituents of Chrysanthemum morifoliuin and their pharmacologic activities Drug Eval Res 2015 38 1 98 104 10.7501/j.issn.1674-6376.2015.01.019 QU L, WANG T, DONG Y Z, et al . Research progress on chemical constituents of Chrysanthemum morifoliuin and their pharmacologic activities[J ] . Drug Eval Res, 2015, 38(1): 98-104. DOI:10.7501/j.issn.1674-6376.2015.01.019.

YAO L LI J LI L Coreopsis tinctoria Nutt ameliorates high glucose-induced renal fibrosis and inflammation via the TGF-β1/SMADS/AMPK/NF-κB pathways BMC Complement Altern Med 2019 19 1 14 10.1186/s12906-018-2410-7 YAO L, LI J, LI L, et al . Coreopsis tinctoria Nutt ameliorates high glucose-induced renal fibrosis and inflammation via the TGF-β1/SMADS/AMPK/NF-κB pathways[J ] . BMC Complement Altern Med, 2019, 19(1): 14. DOI: 10.1186/s12906-018-2410-7.

阿力腾布鲁克李琳琳王丽凤两色金鸡菊提取物及其单体化合物体外抗凝血作用的研究新疆医科大学学报 2019 42 3 368 371, 377 10.3969/j.issn.1009-5551.2019.03.021 阿力腾布鲁克, 李琳琳, 王丽凤, 等. 两色金鸡菊提取物及其单体化合物体外抗凝血作用的研究[J]. 新疆医科大学学报, 2019, 42(3): 368-371, 377. DOI:10.3969/j.issn.1009-5551.2019.03.021.

ALITENGBULUKE LI L L WANG L F Study on anticoagulant effect of extracts from Coreopsis tinctoria Nutt and its monomers in vitro J Xinjiang Med Univ 2019 42 3 368 371, 377 10.3969/j.issn.1009-5551.2019.03.021 ALITENGBULUKE, LI L L, WANG L F, et al . Study on anticoagulant effect of extracts from Coreopsis tinctoria Nutt and its monomers in vitro [J ] . J Xinjiang Med Univ, 2019, 42(3): 368-371, 377. DOI:10.3969/j.issn.1009-5551.2019.03.021.

KIM H G JUNG Y S OH S M Coreolanceolins A-E, new flavanones from the flowers of coreopsis lanceolate, and their antioxidant and anti-inflammatory effects Antioxidants (Basel) 2020 9 6 539 10.3390/antiox9060539 KIM H G, JUNG Y S, OH S M, et al . Coreolanceolins A-E, new flavanones from the flowers of coreopsis lanceolate, and their antioxidant and anti-inflammatory effects[J ] . Antioxidants (Basel), 2020, 9(6): 539. DOI: 10.3390/antiox9060539.

毛新民韩雪卢伟两色金鸡菊对糖尿病小鼠血糖、血脂的影响中药药理与临床 2014 30 2 78 82 毛新民, 韩雪, 卢伟, 等. 两色金鸡菊对糖尿病小鼠血糖、血脂的影响[J]. 中药药理与临床, 2014, 30(2): 78-82.

MAO X M HAN X LU W Effect of the ethyl acetate extract from Coreopsis tinctoria nutt. on fasting blood levels and blood lipids in diabetic mice Pharmacol Clin Chin Mater Med 2014 30 2 78 82 MAO X M, HAN X, LU W, et al . Effect of the ethyl acetate extract from Coreopsis tinctoria nutt. on fasting blood levels and blood lipids in diabetic mice[J ] . Pharmacol Clin Chin Mater Med, 2014, 30(2): 78-82.

毛新民卢伟李琳琳两色金鸡菊化学成分和药理作用研究进展中国药物应用与监测 2014 11 4 235 239 毛新民, 卢伟, 李琳琳, 等. 两色金鸡菊化学成分和药理作用研究进展[J]. 中国药物应用与监测, 2014, 11(4): 235-239.

MAO X M LU W LI L L The progress of chemical constituents and pharmacological action of Coreopsis tinctoria Nutt Chin J Drug Appl Monit 2014 11 4 235 239 MAO X M, LU W, LI L L, et al . The progress of chemical constituents and pharmacological action of Coreopsis tinctoria Nutt[J ] . Chin J Drug Appl Monit, 2014, 11(4): 235-239.

张旭华王烨李琳琳两色金鸡菊提取物对胰岛素抵抗小鼠肠道菌群的影响新疆医科大学学报 2020 43 6 786 791 10.3969/j.issn.1009-5551.2020.06.023 张旭华, 王烨, 李琳琳, 等. 两色金鸡菊提取物对胰岛素抵抗小鼠肠道菌群的影响[J]. 新疆医科大学学报, 2020, 43(6): 786-791. DOI:10.3969/j.issn.1009-5551.2020.06.023.

ZHANG X H WANG Y LI L L Effect of extract from Coreopsis tinctoria Nutt on the intestinal microbiota in insulin resistant mice J Xinjiang Med Univ 2020 43 6 786 791 10.3969/j.issn.1009-5551.2020.06.023 ZHANG X H, WANG Y, LI L L, et al . Effect of extract from Coreopsis tinctoria Nutt on the intestinal microbiota in insulin resistant mice[J ] . J Xinjiang Med Univ, 2020, 43(6): 786-791. DOI:10.3969/j.issn.1009-5551.2020.06.023.

ZHANG N N KANG J S LIU S S Flavanomarein inhibits high glucose-stimulated epithelial-mesenchymal transition in HK-2 cells via targeting spleen tyrosine kinase Sci Rep 2020 10 1 439 10.1038/s41598-019-57360-4 ZHANG N N, KANG J S, LIU S S, et al . Flavanomarein inhibits high glucose-stimulated epithelial-mesenchymal transition in HK-2 cells via targeting spleen tyrosine kinase[J ] . Sci Rep, 2020, 10(1): 439. DOI: 10.1038/s41598-019-57360-4.

LE L FU H LV Q The protective effects of the native flavanone flavanomarein on neuronal cells damaged by 6-OHDA Phytomedicine 2019 53 193 204 10.1016/j.phymed.2018.09.005 LE L, FU H, LV Q, et al . The protective effects of the native flavanone flavanomarein on neuronal cells damaged by 6-OHDA[J ] . Phytomedicine, 2019, 53: 193-204. DOI: 10.1016/j.phymed.2018.09.005.

张永威李新霞王敬伟两色金鸡菊中马里苷和黄诺玛苷的制备及其均匀性研究新疆医科大学学报 2020 43 3 340 343 10.3969/j.issn.1009-5551.2020.03.024 张永威, 李新霞, 王敬伟, 等. 两色金鸡菊中马里苷和黄诺玛苷的制备及其均匀性研究[J]. 新疆医科大学学报, 2020, 43(3): 340-343. DOI:10.3969/j.issn.1009-5551.2020.03.024.

ZHANG Y W LI X X WANG J W Preparation of certified reference material and the homogeneity of flavanomarein and marein from Coreopsis trinctoria Nutt J Xinjiang Med Univ 2020 43 3 340 343 10.3969/j.issn.1009-5551.2020.03.024 ZHANG Y W, LI X X, WANG J W, et al . Preparation of certified reference material and the homogeneity of flavanomarein and marein from Coreopsis trinctoria Nutt[J ] . J Xinjiang Med Univ, 2020, 43(3): 340-343. DOI:10.3969/j.issn.1009-5551.2020.03.024.

DAINA A MICHIELIN O ZOETE V Swiss-target prediction: updated data and new features for efficient prediction of protein targets of small molecules Nucleic Acids Res 2019 47 W1 W357 W364 10.1093/nar/gkz382 DAINA A, MICHIELIN O, ZOETE V. Swiss-target prediction: updated data and new features for efficient prediction of protein targets of small molecules[J]. Nucleic Acids Res, 2019, 47(W1): W357-W364. DOI:10.1093/nar/gkz382.

KIM S CHEN J CHENG T J PubChem 2019 update: improved access to chemical data Nucleic Acids Res 2019 47 D1 D1102 D1109 10.1093/nar/gky1033 KIM S, CHEN J, CHENG T J, et al . PubChem 2019 update: improved access to chemical data[J ] . Nucleic Acids Res, 2019, 47(D1): D1102-D1109. DOI:10.1093/nar/gky1033.

PIÑERO J RAMÍREZ-ANGUITA J M SAVCH-PITARCH J The DisGeNET knowledge platform for disease genomics: 2019 update Nucleic Acids Res 2020 48 D1 D845 D855 10.1093/nar/gkz1021 PIÑERO J, RAMÍREZ-ANGUITA J M, SAVCH-PITARCH J, et al . The DisGeNET knowledge platform for disease genomics: 2019 update[J ] . Nucleic Acids Res, 2020, 48(D1): D845-D855. DOI:10.1093/nar/gkz1021.

CONSORTIUM T U UniProt: a worldwide hub of protein knowledge Nucleic Acids Res 2018 47 D1 D506 D515 10.1093/nar/gky1049 CONSORTIUM T U. UniProt: a worldwide hub of protein knowledge[J]. Nucleic Acids Res, 2018, 47(D1): D506-D515. DOI: 10.1093/nar/gky1049.

MARTIN A OCHAGAVIA M E RABASA L C BisoGenet: a new tool for gene network building, visualization and analysis BMC Bioinform 2010 11 91 10.1186/1471-2105-11-91 MARTIN A, OCHAGAVIA M E, RABASA L C, et al . BisoGenet: a new tool for gene network building, visualization and analysis[J ] . BMC Bioinform, 2010, 11: 91. DOI:10.1186/1471-2105-11-91.

ZHOU Y Y ZHOU B PACHE L Metascape provides a biologist-oriented resource for the analysis of systems-level datasets Nat Commun 2019 10 1 1523 10.1038/s41467-019-09234-6 ZHOU Y Y, ZHOU B, PACHE L, et al . Metascape provides a biologist-oriented resource for the analysis of systems-level datasets[J ] . Nat Commun, 2019, 10(1): 1523. DOI:10.1038/s41467-019-09234 -6.

OTASEK D MORRIS J H BOUÇAS J Cytoscape Automation: empowering workflow-based network analysis Genome Biol 2019 20 1 185 10.1186/s13059-019-1758-4 OTASEK D, MORRIS J H, BOUÇAS J, et al . Cytoscape Automation: empowering workflow-based network analysis[J ] . Genome Biol, 2019, 20(1): 185. DOI: 10.1186/s13059-019-1758-4.

DE A DUSEJA A Natural history of simple steatosis or nonalcoholic fatty liver J Clin Exp Hepatol 2020 10 3 255 262 10.1016/j.jceh.2019.09.005 DE A, DUSEJA A. Natural history of simple steatosis or nonalcoholic fatty liver[J]. J Clin Exp Hepatol, 2020, 10(3): 255-262. DOI:10.1016/j.jceh.2019.09.005.

ARSHAD T GOLABI P HENRY L Epidemiology of non-alcoholic fatty liver disease in North America Curr Pharm Des 2020 26 10 993 997 10.2174/1381612826666200303114934 ARSHAD T, GOLABI P, HENRY L, et al . Epidemiology of non-alcoholic fatty liver disease in North America[J ] . Curr Pharm Des, 2020, 26(10): 993-997. DOI:10.2174/1381612826666200303114934.

SHAUNAK M BYRNE C D DAVIS N Non-alcoholic fatty liver disease and childhood obesity Arch Dis Child 2021 106 1 3 8 10.1136/archdischild-2019-318063 SHAUNAK M, BYRNE C D, DAVIS N, et al . Non-alcoholic fatty liver disease and childhood obesity[J ] . Arch Dis Child, 2021, 106(1): 3-8. DOI: 10.1136/archdischild-2019-318063.

KUMAR R PRIYADARSHI R N ANAND U Non-alcoholic fatty liver disease: growing burden, adverse outcomes and associations J Clin Transl Hepatol 2020 8 1 76 86 10.14218/jcth.2019.00051 KUMAR R, PRIYADARSHI R N, ANAND U. Non-alcoholic fatty liver disease: growing burden, adverse outcomes and associations[J]. J Clin Transl Hepatol, 2020, 8(1): 76-86. DOI:10.14218/jcth.2019.00051.

FANG Y L CHEN H WANG C L Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model" World J Gastroenterol 2018 24 27 2974 2983 10.3748/wjg.v24.i27.2974 FANG Y L, CHEN H, WANG C L, et al . Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model"[J ] . World J Gastroenterol, 2018, 24(27): 2974-2983. DOI:10.3748/wjg.v24.i27.2974.

MENDEL M CHŁOPECKA M LATEK U Evaluation of the effects of Bidens tripartita extracts and their main constituents on intestinal motility : An ex vivo st udy J Ethnopharmacol 2020 259 112982 10.1016/j.jep.2020.112982 MENDEL M, CHŁOPECKA M, LATEK U, et al . Evaluation of the effects of Bidens tripartita extracts and their main constituents on intestinal motility : An ex vivo study[J ] . J Ethnopharmacol, 2020, 259: 112982. DOI: 10.1016/j.jep.2020.112982.

CHYAU C C WANG H F ZHANG W J Antrodan alleviates high-fat and high-fructose diet-induced fatty liver disease in C57BL/6 mice model via AMPK/Sirt1/SREBP-1c/PPARγ pathway Int J Mol Sci 2020 21 1 360 10.3390/ijms21010360 CHYAU C C, WANG H F, ZHANG W J, et al . Antrodan alleviates high-fat and high-fructose diet-induced fatty liver disease in C57BL/6 mice model via AMPK/Sirt1/SREBP-1c/PPARγ pathway[J ] . Int J Mol Sci, 2020, 21(1): 360. DOI:10.3390/ijms21010360.

LIU E WANG X LI X Co-exposure to multi-walled carbon nanotube and lead ions aggravates hepatotoxic ity of nonalcoholic fatty liver via inhibiting AMPK/PPARγ pathway Aging (Albany NY) 2020 12 14 14189 14204 10.18632/aging.103430 LIU E, WANG X, LI X, et al . Co-exposure to multi-walled carbon nanotube and lead ions aggravates hepatotoxicity of nonalcoholic fatty liver via inhibiting AMPK/PPARγ pathway[J ] . Aging (Albany NY), 2020, 12(14): 14189-14204. DOI: 10.18632/aging.103430.

黄旦刘健纵瑞凯黄芩清热除痹胶囊激活PPARγ介导AMPK/FOXO3a信号通路改善强直性脊柱炎患者氧化应激中国中药杂志 2020 45 2 451 456 10.19540/j.cnki.cjcmm.20190619.501 黄旦, 刘健, 纵瑞凯, 等. 黄芩清热除痹胶囊激活PPARγ介导AMPK/FOXO3a信号通路改善强直性脊柱炎患者氧化应激[J]. 中国中药杂志, 2020, 45(2): 451-456. DOI:10.19540/j.cnki.cjcmm.20190619.501.

HUANG D LIU J ZONG R K Huangqin Qingre Chubi Capsules in improving oxidative stress of patients with ankylosing spondylitis via activating PPARγmediated AMPK/FOXO3a pathway China J Chin Mat Med 2020 45 2 451 456 10.19540/j.cnki.cjcmm.20190619.501 HUANG D, LIU J, ZONG R K, et al . Huangqin Qingre Chubi Capsules in improving oxidative stress of patients with ankylosing spondylitis via activating PPARγmediated AMPK/FOXO3a pathway[J ] . China J Chin Mat Med, 2020, 45(2): 451-456. DOI:10.19540/j.cnki.cjcmm.20190619.501.

JIA Q CAO H SHEN D Quercetin protects against atherosclerosis by regulating the expression of PCSK9, CD36, PPARγ, LXRα and ABCA1 Int J Mol Med 2019 44 3 893 902 10.3892/ijmm.2019.4263 JIA Q, CAO H, SHEN D, et al . Quercetin protects against atherosclerosis by regulating the expression of PCSK9, CD36, PPARγ, LXRα and ABCA1[J ] . Int J Mol Med, 2019, 44(3): 893-902. DOI:10.3892/ijmm.2019.4263.

ZHANG L QIAO X CHEN M Ilexgenin A prevents early colonic carcinogenesis and reprogramed lipid metabolism through HIF1α/SREBP-1 Phytomedicine 2019 63 153011 10.1016/j.phymed.2019.153011 ZHANG L, QIAO X, CHEN M, et al . Ilexgenin A prevents early colonic carcinogenesis and reprogramed lipid metabolism through HIF1α/SREBP-1[J ] . Phytomedicine, 2019, 63: 153011. DOI:10.1016/j.phymed.2019.153011.

LIN Q HUANG Z CAI G Activating AMP-activated protein kinase mediates fibroblast growth factor 1 protection from nonalcoholic fatty liver disease in mice Hepatology 2020 10.1002/hep.31568 LIN Q, HUANG Z, CAI G, et al . Activating AMP-activated protein kinase mediates fibroblast growth factor 1 protection from nonalcoholic fatty liver disease in mice[J ] . Hepatology, 2020. DOI: 10.1002/hep.31568.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Z-Ligustilide ameliorates retinitis pigmentosa via inhibiting PI3K/AKT-inflammation axis: Validation based on network pharmacology and molecular docking

Quercetin inhibits ferroptosis to alleviate intestinal ischemia-reperfusion injury

Bergapten alleviates senescence of chondrocytes in osteoarthritis

Mechanism of Tongguan Pills in treatment for tubal factor infertility based on bioinformatics combined with network pharmacology and molecular docking

Chidamide combined with mycophenolate mofetil suppress proliferation of secondary acute myeloid leukemia cells

Related Author

XU Haiwei

HUO Shujia

XIAO Weizuo

GE Lingling

A Luodan

DENG Jiaxing

MA Xiaojie

LENG Yufang

Related Institution

Department of Ophthalmology， First Affiliated Hospital， Army Medical University （Third Military Medical University）

Department of Ophthalmology， General Hospital of Southern Theater Command

First Clinical Medical College of Lanzhou University

Department of Anesthesiology and Surgery， the First Hospital of Lanzhou University

Department of Cell Biology and Genetics， College of Basic Medical Sciences， Chongqing Medical University

⁰